PPD Polandsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
PPD Poland provides services as a global contract research organization (CRO), supporting drug development and clinical studies across more than 20 therapeutic areas. Its offering includes project management, laboratory services, support for biotech companies and digital solutions using data, predictive analytics and artificial intelligence.
Financials
Revenue history (in m)
From the notes
| Profit allocation | Retained in reserve capital | |
| Deferred tax assets | $1,059,482 | |
| Deferred tax liability | $13,878 | |
| Audit firm | Crowe Advartis Accounting Sp. z o.o. | |
| Related parties | 5 items | |
| Parent company | PPD International Holding GmbH |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 122 days for 2022). All were audited by a statutory auditor.
- 2025filed
- 202403/07/2025
- 202325/09/2024
- 202214/11/2023
- 202127/09/2022
- 202014/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Website technology
- Website
- WordPress
- Contact and booking
- HubSpot
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Manner of representation
Member of the management board independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ppd International Holdings Gmbh | 10,040 | $271,204.75 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-10-01.
78 1880 0009 0000 0011 0233 6001- 08 1880 0009 0000 0011 0233 6000
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.1MPLN 1,127,316 |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polpharma BiologicsS.A. | $311,661,837.06 | polpharmabiologics.com | ||
| Iqvia Rds Polandsp. z o.o. | $67,221,056.87 | iqvia.com | ||
| KCRS.A. | $43,596,034.97 | kcrcro.com | ||
| Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju TechnologiiResearch institute | $24,232,583.73 | port.lukasiewicz.gov.pl | ||
| Kapadisp. z o.o. | $7,248,714.39 | kapadi.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-06-26 | PKD change (Removed: 70.21.Z, 71.20.A, 73.11.Z, 73.20.Z, 85.60.Z, 96.09.Z) | |
| 2010-04-29 | Switch to PKD 2007 (6 PKD 2004 codes → 16 PKD 2007 codes) | |
| 2009-09-09 | Address change (Postępu 18 B, 02-676, Warszawa → Domaniewska 49, 02-672, Warszawa) | |
| 2006-12-22 | Address change (Domaniewska 41, 02-672, Warszawa → Postępu 18 B, 02-676, Warszawa) | |
| 2002-08-27 | Entered in the register |
FAQ
Last updated: 2026-10-07